{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T07:10:43Z","timestamp":1776064243004,"version":"3.50.1"},"reference-count":86,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology and Applied Pharmacology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.taap.2024.116870","type":"journal-article","created":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T11:21:13Z","timestamp":1708514473000},"page":"116870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Efficacy of a combined anti-seizure treatment against cholinergic established status epilepticus following a sarin nerve agent insult in rats"],"prefix":"10.1016","volume":"484","author":[{"given":"Shlomi","family":"Lazar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adi","family":"Neufeld-Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inbal","family":"Egoz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shlomi","family":"Baranes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rellie","family":"Gez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pnina","family":"Glick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maayan","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hila","family":"Gutman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shira","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariel","family":"Gore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.taap.2024.116870_bb0005","doi-asserted-by":"crossref","DOI":"10.1590\/1414-431x20165646","article-title":"Non-clinical studies in the process of new drug development - Part II: good laboratory practice, metabolism, pharmacokinetics, safety and dose translation to clinical studies","volume":"49","author":"Andrade","year":"2016","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"2","key":"10.1016\/j.taap.2024.116870_bb0010","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1124\/jpet.114.217299","article-title":"The limitations of diazepam as a treatment for nerve agent-induced seizures and neuropathology in rats: comparison with UBP302","volume":"351","author":"Apland","year":"2014","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.taap.2024.116870_bb0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0065-2423(04)38006-6","article-title":"Organophosphates\/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis, and treatment","volume":"38","author":"Bajgar","year":"2004","journal-title":"Adv. Clin. Chem."},{"issue":"1","key":"10.1016\/j.taap.2024.116870_bb0020","doi-asserted-by":"crossref","DOI":"10.1002\/0471142301.ns0716s09","article-title":"Peripheral type benzodiazepine binding sites as a tool for the detection and quantification of CNS injury","volume":"9","author":"Benavides","year":"1999","journal-title":"Curr. Protoc. Neurosci."},{"issue":"2","key":"10.1016\/j.taap.2024.116870_bb0025","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.neuro.2005.11.009","article-title":"Seizure duration following sarin exposure affects neuro-inflammatory markers in the rat brain","volume":"27","author":"Chapman","year":"2006","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.taap.2024.116870_bb0030","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.neuro.2015.05.001","article-title":"Sarin-induced brain damage in rats is attenuated by delayed administration of midazolam","volume":"49","author":"Chapman","year":"2015","journal-title":"Neurotoxicology"},{"issue":"1","key":"10.1016\/j.taap.2024.116870_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pharmthera.2007.12.004","article-title":"Translocator protein 18 kDa (TSPO): molecular sensor of brain injury and repair","volume":"118","author":"Chen","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.taap.2024.116870_bb0045","series-title":"Curr Protoc Neurosci Appendix 4:Appendix 4B","article-title":"Mouse and rat anesthesia and analgesia","author":"Davis","year":"2008"},{"issue":"7","key":"10.1016\/j.taap.2024.116870_bb0050","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1528-1167.2010.02519.x","article-title":"High-dose intravenous levetiracetam for acute seizure exacerbation in children with intractable epilepsy","volume":"51","author":"Depositario-Cabacar","year":"2010","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.taap.2024.116870_bb0055","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/096032719301200101","article-title":"Behavioural toxicity of anticholinesterases in humans and animals--a review","volume":"12","author":"D\u2019Mello","year":"1993","journal-title":"Hum. Exp. Toxicol."},{"issue":"10","key":"10.1016\/j.taap.2024.116870_bb0060","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1038\/nm1013-1194","article-title":"Syrian gas attack reinforces need for better anti-sarin drugs","volume":"19","author":"Dolgin","year":"2013","journal-title":"Nat. Med."},{"issue":"1\u20132","key":"10.1016\/j.taap.2024.116870_bb0065","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.brainres.2005.06.013","article-title":"Efficacy of the ketamine-atropine combination in the delayed treatment of soman-induced status epilepticus","volume":"1051","author":"Dorandeu","year":"2005","journal-title":"Brain Res."},{"issue":"5","key":"10.1016\/j.taap.2024.116870_bb0070","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1001\/jama.1989.03430050065028","article-title":"Progress in medical defense against nerve agents","volume":"262","author":"Dunn","year":"1989","journal-title":"Jama"},{"key":"10.1016\/j.taap.2024.116870_bb0075","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neuro.2020.03.007","article-title":"Evaluation of fosphenytoin, levetiracetam, and propofol as treatments for nerve agent-induced seizures in pediatric and adult rats","volume":"79","author":"Dunn","year":"2020","journal-title":"NeuroToxicology"},{"issue":"9612","key":"10.1016\/j.taap.2024.116870_bb0080","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0140-6736(07)61202-1","article-title":"Management of acute organophosphorus pesticide poisoning","volume":"371","author":"Eddleston","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.taap.2024.116870_bb0085","first-page":"67","article-title":"Review and update of the Hong Kong epilepsy guideline on status epilepticus","volume":"23","author":"Fung","year":"2017","journal-title":"Hong Kong Med. J."},{"issue":"2","key":"10.1016\/j.taap.2024.116870_bb0090","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.eplepsyres.2006.09.005","article-title":"Administration of levetiracetam after prolonged status epilepticus does not protect from mitochondrial dysfunction in a rodent model","volume":"73","author":"Gibbs","year":"2007","journal-title":"Epilepsy Res."},{"issue":"3","key":"10.1016\/j.taap.2024.116870_bb0095","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1528-1167.2006.00454.x","article-title":"Levetiracetam: antiepileptic properties and protective effects on mitochondrial dysfunction in experimental status epilepticus","volume":"47","author":"Gibbs","year":"2006","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.taap.2024.116870_bb0100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00204-002-0425-8","article-title":"Nasal midazolam as a novel anticonvulsive treatment against organophosphate-induced seizure activity in the guinea pig","volume":"77","author":"Gilat","year":"2003","journal-title":"Arch. Toxicol."},{"issue":"1","key":"10.1016\/j.taap.2024.116870_bb0105","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.taap.2005.03.007","article-title":"Anticonvulsant treatment of sarin-induced seizures with nasal midazolam: an electrographic, behavioral, and histological study in freely moving rats","volume":"209","author":"Gilat","year":"2005","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2024.116870_bb0110","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline Committee of the American Epilepsy Society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy. Curr."},{"issue":"Suppl 8(Suppl 8)","key":"10.1016\/j.taap.2024.116870_bb0115","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1528-1167.2007.01337.x","article-title":"Impact of receptor changes on treatment of status epilepticus","volume":"48","author":"Goodkin","year":"2007","journal-title":"Epilepsia"},{"issue":"10","key":"10.1016\/j.taap.2024.116870_bb0120","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1523\/JNEUROSCI.3426-07.2008","article-title":"Subunit-specific trafficking of GABA(A) receptors during status epilepticus","volume":"28","author":"Goodkin","year":"2008","journal-title":"J. Neurosci."},{"issue":"2","key":"10.1016\/j.taap.2024.116870_bb0125","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/toxsci\/kfv092","article-title":"Synergism between anticholinergic and oxime treatments against sarin-induced ocular insult in rats","volume":"146","author":"Gore","year":"2015","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.taap.2024.116870_bb0130","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2020.114963","article-title":"Efficacy of retigabine in ameliorating the brain insult following sarin exposure in the rat","volume":"395","author":"Gore","year":"2020","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2024.116870_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2021.115519","article-title":"Neuroprotection by delayed triple therapy following sarin nerve agent insult in the rat","volume":"419","author":"Gore","year":"2021","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.taap.2024.116870_bb0140","series-title":"Epilepsy","article-title":"Modern treatment of status epilepticus in adults","author":"Heuser","year":"2022"},{"issue":"4","key":"10.1016\/j.taap.2024.116870_bb0145","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1136\/jnnp.2004.041947","article-title":"Predictors and prognosis of refractory status epilepticus treated in a neurological intensive care unit","volume":"76","author":"Holtkamp","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.taap.2024.116870_bb0150","series-title":"Medical Management of Chemical Casualties Handbook. Chemical Casualty Care Division, US Army Medical Research Institute of Chemical defense 3100 Ricketts Point Road Aberdeen Proving Ground, MD 21010-5400","author":"Hurst","year":"2007"},{"key":"10.1016\/j.taap.2024.116870_bb0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vascn.2019.02.006","article-title":"Validating a model of benzodiazepine refractory nerve agent-induced status epilepticus by evaluating the anticonvulsant and neuroprotective effects of scopolamine, memantine, and phenobarbital","volume":"97","author":"Jackson","year":"2019","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"10.1016\/j.taap.2024.116870_bb0160","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1476-5381.2010.00872.x","article-title":"NC3Rs reporting guidelines working group","volume":"160","author":"Kilkenny","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.taap.2024.116870_bb0165","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1124\/jpet.107.126250","article-title":"Antiepileptic drug-induced neuronal cell death in the immature brain: effects of carbamazepine, topiramate, and levetiracetam as monotherapy versus polytherapy","volume":"323","author":"Kim","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"3","key":"10.1016\/j.taap.2024.116870_bb0170","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/0887-8994(92)90071-6","article-title":"Midazolam in treatment of epileptic seizures","volume":"8","author":"Lahat","year":"1992","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.taap.2024.116870_bb0175","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.taap.2016.09.008","article-title":"Propagation of damage in the rat brain following sarin exposure: Differential progression of early processes","volume":"310","author":"Lazar","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"Suppl. 12","key":"10.1016\/j.taap.2024.116870_bb0180","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1528-1167.2009.02367.x","article-title":"Molecular mechanisms of drug resistance in status epilepticus","volume":"50","author":"L\u00f6scher","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.taap.2024.116870_bb0185","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yebeh.2015.02.027","article-title":"Single versus combinatorial therapies in status epilepticus: Novel data from preclinical models","volume":"49","author":"L\u00f6scher","year":"2015","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.taap.2024.116870_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108444","article-title":"Treatment of acetylcholinesterase inhibitor-induced seizures with polytherapy targeting GABA and glutamate receptors","volume":"185","author":"Lumley","year":"2021","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.taap.2024.116870_bb0195","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1590\/S0102-09352004000300009","article-title":"Comparative study of the sedative and antinociceptive effects of levomepromazine, azaperone and midazolam in laboratory animals","volume":"56","author":"Mataqueiro","year":"2004","journal-title":"Arquivo Brasil. Med. Vet. Zoot."},{"issue":"2","key":"10.1016\/j.taap.2024.116870_bb0200","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1001\/archneur.59.2.205","article-title":"Refractory status epilepticus: frequency, risk factors, and impact on outcome","volume":"59","author":"Mayer","year":"2002","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.taap.2024.116870_bb0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2018.01.010","article-title":"Dexmedetomidine stops benzodiazepine-refractory nerve agent-induced status epilepticus","volume":"141","author":"McCarren","year":"2018","journal-title":"Epilepsy Res."},{"issue":"2","key":"10.1016\/j.taap.2024.116870_bb0210","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0149-7634(05)80151-4","article-title":"Pharmacological modulation of soman-induced seizures","volume":"17","author":"McDonough","year":"1993","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2\u20133","key":"10.1016\/j.taap.2024.116870_bb0215","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/0091-3057(94)00372-P","article-title":"A study of the N-methyl-d-aspartate antagonistic properties of anticholinergic drugs","volume":"51","author":"McDonough","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"5","key":"10.1016\/j.taap.2024.116870_bb0220","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S0149-7634(96)00050-4","article-title":"Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology","volume":"21","author":"McDonough","year":"1997","journal-title":"Neurosci. Biobehav. Rev."},{"issue":"2","key":"10.1016\/j.taap.2024.116870_bb0225","first-page":"179","article-title":"Behavioral correlates of soman-induced neuropathology: deficits in DRL acquisition","volume":"8","author":"McDonough","year":"1986","journal-title":"Neurobehav. Toxicol. Teratol."},{"issue":"3","key":"10.1016\/j.taap.2024.116870_bb0230","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3109\/01480540903483417","article-title":"Time-dependent reduction in the anticonvulsant effectiveness of diazepam against soman-induced seizures in guinea pigs","volume":"33","author":"McDonough","year":"2010","journal-title":"Drug Chem. Toxicol."},{"issue":"7","key":"10.1016\/j.taap.2024.116870_bb0235","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1111\/j.1476-5381.2010.00873.x","article-title":"Guidelines for reporting experiments involving animals: the ARRIVE guidelines","volume":"160","author":"McGrath","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.taap.2024.116870_bb0240","first-page":"53","article-title":"Acute neuropathology in soman poisoned rats","volume":"5","author":"McLeod","year":"1984","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.taap.2024.116870_bb0245","article-title":"Drug management for acute tonic-clonic convulsions including convulsive status epilepticus in children","volume":"1","author":"McTague","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"issue":"1","key":"10.1016\/j.taap.2024.116870_bib427","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pbb.2010.11.022","article-title":"Impaired auditory and contextual fear conditioning in soman-exposed rats","volume":"98","author":"Moffett","year":"2011","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.taap.2024.116870_bb0250","series-title":"Review of Nerve Agent Inhibitors and Reactivators of Acetylcholinesterase Enzymes of the cholinesterase Family","first-page":"297","author":"Moore","year":"1995"},{"issue":"1","key":"10.1016\/j.taap.2024.116870_bb0255","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1289\/ehp.9410218","article-title":"Toxicity of the organophosphate chemical warfare agents GA, GB, and VX: implications for public protection","volume":"102","author":"Munro","year":"1994","journal-title":"Environ. Health Perspect."},{"issue":"2","key":"10.1016\/j.taap.2024.116870_bb0265","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"issue":"34","key":"10.1016\/j.taap.2024.116870_bb0270","doi-asserted-by":"crossref","first-page":"7724","DOI":"10.1523\/JNEUROSCI.4944-04.2005","article-title":"Trafficking of GABA(A) receptors, loss of inhibition, and a mechanism for pharmacoresistance in status epilepticus","volume":"25","author":"Naylor","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.taap.2024.116870_bb0275","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.nbd.2012.12.015","article-title":"Rapid surface accumulation of NMDA receptors increases glutamatergic excitation during status epilepticus","volume":"54","author":"Naylor","year":"2013","journal-title":"Neurobiol. Dis."},{"issue":"9","key":"10.1016\/j.taap.2024.116870_bb0280","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/epi.13480","article-title":"Midazolam-ketamine dual therapy stops cholinergic status epilepticus and reduces Morris water maze deficits","volume":"57","author":"Niquet","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.taap.2024.116870_bb0285","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2017.04.019","article-title":"Simultaneous triple therapy for the treatment of status epilepticus","volume":"104","author":"Niquet","year":"2017","journal-title":"Neurobiol. Dis."},{"issue":"4","key":"10.1016\/j.taap.2024.116870_bb0290","doi-asserted-by":"crossref","first-page":"e49","DOI":"10.1111\/epi.13695","article-title":"Treatment of experimental status epilepticus with synergistic drug combinations","volume":"58","author":"Niquet","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.taap.2024.116870_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2019.104537","article-title":"Rational polytherapy in the treatment of cholinergic seizures","volume":"133","author":"Niquet","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"1","key":"10.1016\/j.taap.2024.116870_bb0300","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.eplepsyres.2010.06.009","article-title":"Efficacy and tolerability of high oral doses of levetiracetam in children with epilepsy","volume":"91","author":"Obeid","year":"2010","journal-title":"Epilepsy Res."},{"issue":"4","key":"10.1016\/j.taap.2024.116870_bib428","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.yebeh.2009.02.018","article-title":"Intravenous midazolam in convulsive status epilepticus in children with pharmacoresistant epilepsy","volume":"14","author":"Papavasiliou","year":"2009","journal-title":"Epilepsy Behav"},{"issue":"10","key":"10.1016\/j.taap.2024.116870_bb0305","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1212\/WNL.44.10.1837","article-title":"Treatment of refractory generalized status epilepticus with continuous infusion of midazolam","volume":"44","author":"Parent","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.taap.2024.116870_bib426","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1986"},{"issue":"12","key":"10.1016\/j.taap.2024.116870_bb0310","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1177\/088307389801301201","article-title":"Use of midazolam for refractory status epilepticus in pediatric patients","volume":"13","author":"Pellock","year":"1998","journal-title":"J. Child Neurol."},{"issue":"9","key":"10.1016\/j.taap.2024.116870_bb0315","article-title":"Anticonvulsant therapy for status epilepticus","volume":"2014","author":"Prasad","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.taap.2024.116870_bb0320","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s13311-018-0640-5","article-title":"Treatment of refractory and super-refractory status epilepticus","volume":"15","author":"Rai","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"1","key":"10.1016\/j.taap.2024.116870_bb0325","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/toxsci\/kfg166","article-title":"Anticholinergic and antiglutamatergic agents protect against soman-induced brain damage and cognitive dysfunction","volume":"75","author":"Raveh","year":"2003","journal-title":"Toxicol. Sci."},{"issue":"1","key":"10.1016\/j.taap.2024.116870_bb0330","first-page":"2305","article-title":"Clinical pharmacology of current antiepileptic drugs","volume":"7","author":"Reddy","year":"2014","journal-title":"Int. J. Pharma. Sci. Nanotechnol."},{"issue":"1","key":"10.1016\/j.taap.2024.116870_bb0335","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/nyas.13160","article-title":"Neurosteroids for the potential protection of humans against organophosphate toxicity","volume":"1378","author":"Reddy","year":"2016","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"9","key":"10.1016\/j.taap.2024.116870_bb0340","doi-asserted-by":"crossref","first-page":"644","DOI":"10.7326\/M13-2799","article-title":"Lessons learned from the Syrian sarin attack: evaluation of a clinical syndrome through social media","volume":"160","author":"Rosman","year":"2014","journal-title":"Ann. Intern. Med."},{"issue":"10","key":"10.1016\/j.taap.2024.116870_bb0345","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S1474-4422(11)70187-9","article-title":"Management of refractory status epilepticus in adults: still more questions than answers","volume":"10","author":"Rossetti","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.taap.2024.116870_bb0350","first-page":"1","article-title":"Management of convulsions in nerve agent acute poisoning: a polish perspective","volume":"1","author":"Rump","year":"2004","journal-title":"J. Med. Chem. Def."},{"issue":"1","key":"10.1016\/j.taap.2024.116870_bb0355","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0091-3057(99)00114-8","article-title":"Organophosphorus nerve agents-induced seizures and efficacy of atropine sulfate as anticonvulsant treatment","volume":"64","author":"Shih","year":"1999","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"1","key":"10.1016\/j.taap.2024.116870_bb0360","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s12031-009-9253-0","article-title":"Protection against sarin-induced seizures in rats by direct brain microinjection of scopolamine, midazolam or MK-801","volume":"40","author":"Skovira","year":"2010","journal-title":"J. Mol. Neurosci."},{"issue":"3","key":"10.1016\/j.taap.2024.116870_bb0365","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13181-018-0658-4","article-title":"ACMT Position Statement: Alternative or Contingency Countermeasures for Acetylcholinesterase Inhibiting Agents","volume":"14","author":"Stolbach","year":"2018","journal-title":"J. Med. Toxicol."},{"issue":"45","key":"10.1016\/j.taap.2024.116870_bb0370","doi-asserted-by":"crossref","first-page":"16423","DOI":"10.1523\/JNEUROSCI.2506-11.2011","article-title":"The anticonvulsant response to valproate in kindled rats is correlated with its effect on neuronal firing in the substantia nigra pars reticulata: a new mechanism of pharmacoresistance","volume":"31","author":"T\u00f6llner","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.taap.2024.116870_bb0375","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0074-7742(06)81018-4","article-title":"Treatment of convulsive status epilepticus","volume":"81","author":"Treiman","year":"2007","journal-title":"Int. Rev. Neurobiol."},{"issue":"12","key":"10.1016\/j.taap.2024.116870_bb0380","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1056\/NEJM199809173391202","article-title":"A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group","volume":"339","author":"Treiman","year":"1998","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.taap.2024.116870_bb0385","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1007\/s40265-015-0454-2","article-title":"Pharmacotherapy for status epilepticus","volume":"75","author":"Trinka","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.taap.2024.116870_bb0390","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yebeh.2019.02.029","article-title":"PTZ-induced seizures in mice require a revised Racine scale","volume":"95","author":"Van Erum","year":"2019","journal-title":"Epilepsy Behav."},{"issue":"5","key":"10.1016\/j.taap.2024.116870_bb0395","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/1535759720928269","article-title":"Treatment of refractory convulsive status epilepticus: a comprehensive review by the American Epilepsy Society Treatments Committee","volume":"20","author":"Vossler","year":"2020","journal-title":"Epilepsy Curr."},{"issue":"3","key":"10.1016\/j.taap.2024.116870_bb0400","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1046\/j.1471-4159.2003.01568.x","article-title":"Peripheral benzodiazepine receptors: on mice and human brain imaging","volume":"84","author":"Weissman","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.taap.2024.116870_bb0405","series-title":"Pharmacological Antagonists of the Anticholinesterase Agents Cholinesterases and Anticholinesterase Agents","first-page":"883","author":"Wills","year":"1963"},{"issue":"2","key":"10.1016\/j.taap.2024.116870_bb0410","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1124\/jpet.117.247106","article-title":"Midazolam-resistant seizures and brain injury after acute intoxication of diisopropylfluorophosphate, an organophosphate pesticide and surrogate for nerve agents","volume":"367","author":"Wu","year":"2018","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"1","key":"10.1016\/j.taap.2024.116870_bb0415","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jns.2006.06.007","article-title":"Sarin experiences in Japan: acute toxicity and long-term effects","volume":"249","author":"Yanagisawa","year":"2006","journal-title":"J. Neurol. Sci."},{"issue":"4\u20135","key":"10.1016\/j.taap.2024.116870_bb0420","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.neuropharm.2009.12.007","article-title":"Intravenous levetiracetam in the rat pilocarpine-induced status epilepticus model: behavioral, physiological and histological studies","volume":"58","author":"Zheng","year":"2010","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.taap.2024.116870_bb0425","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2022.108917","article-title":"The differential effect of levetiracetam on memory and anxiety in rats","volume":"136","author":"Zwierzy\u0144ska","year":"2022","journal-title":"Epilepsy Behav."}],"container-title":["Toxicology and Applied Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24000681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041008X24000681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T21:06:39Z","timestamp":1758575199000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041008X24000681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":86,"alternative-id":["S0041008X24000681"],"URL":"https:\/\/doi.org\/10.1016\/j.taap.2024.116870","relation":{},"ISSN":["0041-008X"],"issn-type":[{"value":"0041-008X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of a combined anti-seizure treatment against cholinergic established status epilepticus following a sarin nerve agent insult in rats","name":"articletitle","label":"Article Title"},{"value":"Toxicology and Applied Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.taap.2024.116870","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116870"}}